LXXGF - LexaGene Holdings Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development1,670.114446.652446.652446.652
Selling General and Administrative1,802.918344.62455.98878.972
Non Recurring----
Total Operating Expenses3,923.57978.3159.33878.972
Operating Income or Loss-3,923.57-978.31-59.338-78.972
Income from Continuing Operations
Total Other Income/Expenses Net-81.882-3,504.905-0.061-
Earnings Before Interest and Taxes-3,923.57-978.31-59.338-78.972
Interest Expense----
Income Before Tax-4,005.452-4,483.215-59.399-78.972
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-4,005.452-4,483.215-59.399-78.972
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-4,005.452-4,483.215-59.399-78.972
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-4,005.452-4,483.215-59.399-78.972